Hidradenitis Suppurativa (HS) Completed Phase 2 Trials for Ustekinumab (DB05679)

Also known as: Hidradenitis Suppurativa / Hidradenitis / Sweat gland inflammation / Acne inversa

IndicationStatusPhase
DBCOND0054533 (Hidradenitis Suppurativa (HS))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01704534A Proof of Concept Study to Evaluate the Effectiveness of Ustekinumab in Hidradenitis SuppurativaTreatment